Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: News from uspto

I think what may have happened in this case is that since they combined 2-3 reexams on this patent, into one re-examination, that there were two examiners assigned the 3-4 reexam numbers there and they could have transferred all of the combined to one examiner.

Just an opinion...hard to tell with this posting and all the combining going on.

Share
New Message
Please login to post a reply